PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2016.30120163161061-1063Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitusMin Kyong Moonhttp://kjim.org/upload/kjim-2016-301.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2016.301, http://www.kjim.org/upload/kjim-2016-301.pdf
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy10.2147/dmso.s614382014169Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitusDaniel Lorberhttps://www.dovepress.com/getfile.php?fileID=20189
Atherosclerosis10.1016/j.atherosclerosis.2018.06.2992018275e108Novel risk factors in patients with type 2 diabetes mellitus and established cardiovascular diseaseN. Latsabidzehttps://api.elsevier.com/content/article/PII:S0021915018306117?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915018306117?httpAccept=text/plain
The Journal of Korean Diabetes10.4093/jkd.2019.20.1.24201920124Pharmacological Therapy of Peripheral Artery Disease in Patients with Diabetes Mellitus: Cardiovascular Risk Factor ManagementSuk Chonhttps://synapse.koreamed.org/pdf/10.4093/jkd.2019.20.1.24, https://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2019.20.1.24, https://synapse.koreamed.org/DOIx.php?id=10.4093/jkd.2019.20.1.24
Diabetologia10.1007/s001250051083199841111397-1398Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypesNot Available Not Availablehttp://link.springer.com/content/pdf/10.1007/s001250051083.pdf, http://link.springer.com/article/10.1007/s001250051083/fulltext.html, http://link.springer.com/content/pdf/10.1007/s001250051083
The British Journal of Diabetes & Vascular Disease10.1177/1474651408096733200885212-213Erectile dysfunction in diabetes mellitus: a risk factor for cardiovascular diseaseIan W Campbellhttp://journals.sagepub.com/doi/pdf/10.1177/1474651408096733, http://journals.sagepub.com/doi/pdf/10.1177/1474651408096733
Diabetes, Obesity and Metabolism10.1046/j.1463-1326.2003.00284.x200355333-337Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agentsJ. W. Chu, F. Abbasi, T. L. McLaughlin, C. Lamendola, P. Schaaf, T. H. Carlson, E. T. Leary, G. M. Reavenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1463-1326.2003.00284.x
10.1007/978-3-642-59352-92003Cardiovascular Risk in Type 2 Diabetes Mellitushttp://link.springer.com/content/pdf/10.1007/978-3-642-59352-9.pdf, http://link.springer.com/content/pdf/10.1007/978-3-642-59352-9
Current Cardiovascular Risk Reports10.1007/s12170-018-0585-62018128Debunking the Myth of Diabetes Mellitus as Cardiovascular Disease Equivalent: What Took So Long?Erum Iqbal Bajwa, Shaista Malikhttp://link.springer.com/article/10.1007/s12170-018-0585-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12170-018-0585-6.pdf, http://link.springer.com/content/pdf/10.1007/s12170-018-0585-6.pdf
European Heart Journal10.1093/eurheartj/ehz746.0170201940Supplement_1P4992The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetesA Leiherer, A Muendlein, C H Saely, R Laaksonen, M Laaperi, A Vonbank, B Larcher, A Mader, I Baumgartner, P Fraunberger, H Drexelhttp://academic.oup.com/eurheartj/article-pdf/40/Supplement_1/ehz746.0170/30200311/ehz746.0170.pdf, http://academic.oup.com/eurheartj/article-pdf/40/Supplement_1/ehz746.0170/30200311/ehz746.0170.pdf